.png)
Most of us have heard that "high cholesterol" is bad for our hearts. We know we should watch what we eat, exercise, and maybe even take medication if our doctor recommends it. But what many people don't realize is that some of us carry specific genetic variations that can significantly affect how our bodies handle cholesterol and fats, raising our risk for heart disease beyond what lifestyle alone might cause.
Two genes in particular deserve attention: APOE (apolipoprotein E) and APOB (apolipoprotein B). If you've had genetic testing done, you might have heard these terms thrown around. Maybe your doctor mentioned you carry the APOE4 variant, or perhaps you're wondering what these genes actually do. This review breaks down everything you need to know about these two genetic players in heart health, explains the differences between them, and most importantly, shows you what you can do to protect your cardiovascular health if you carry higher-risk variants.
The good news? While you can't change your genes, you absolutely can change how those genes affect your health through targeted lifestyle choices.
Both APOE and APOB are genes that provide instructions for making proteins your body uses to transport cholesterol and other fats through your bloodstream. Think of these proteins as delivery trucks that carry cholesterol to and from different parts of your body. When these delivery systems work well, cholesterol gets where it needs to go without causing problems. When they don't work optimally (which can happen due to genetic variations), cholesterol can build up in your artery walls, leading to the process called atherosclerosis that we discussed in our comprehensive article on cardiovascular disease causes, risk factors, and prevention.
The APOE gene comes in three main versions, called alleles: ε2, ε3, and ε4. Everyone inherits two copies of the APOE gene (one from each parent), so you might be ε3/ε3, ε3/ε4, ε2/ε3, or any other combination.
The ε3 variant is the most common and is considered "neutral." It doesn't particularly increase or decrease your disease risk. The ε2 variant is less common and can actually be protective against some conditions, though it carries its own risks. The ε4 variant is where things get interesting for heart health: carrying one or two copies of APOE4 increases your risk for both Alzheimer’s disease and cardiovascular disease..
Research consistently demonstrates that APOE4 carriers face a significantly higher risk of cardiovascular disease compared to non-carriers. Large-scale population studies and meta-analyses show that individuals carrying the ε4 variant have roughly a 40% to 50% increased baseline risk for coronary heart disease, a risk that can multiply significantly when combined with traditional risk factors like smoking, poor diet, or metabolic dysfunction (Song et al., 2004). This elevated risk occurs because the ApoE4 protein is structurally different from the more common ApoE3 protein, making it far less efficient at binding to the liver receptors responsible for clearing cholesterol from your bloodstream. Consequently, cholesterol lingers in circulation where it is more likely to become trapped in artery walls. Beyond just impaired lipid clearance, the ApoE4 protein has also been shown to actively drive dysfunction in the endothelium (the lining of the blood vessels), worsen vascular inflammation, and disrupt normal metabolic signaling, creating a highly pro-atherosclerotic environment (Safieh et al., 2019).
What makes APOE particularly fascinating is that it affects both your brain and your cardiovascular system. The same protein that influences Alzheimer's risk also plays a role in how your blood vessels function, how inflammation develops, and how your body manages cholesterol metabolism. This explains why lifestyle factors that protect your heart (like eating a Mediterranean diet, exercising regularly, and avoiding smoking) also appear to protect your brain, especially if you carry the APOE4 variant. (Laitinen et al., 2006).
While APOE affects cholesterol transport and clearance, APOB focuses on a different aspect of the cholesterol story. The APOB gene provides instructions for making apolipoprotein B, a protein that sits on the surface of cholesterol-carrying particles. Here's the key point: every single atherogenic particle (cholesterol particle that can contribute to plaque buildup) contains exactly one molecule of apoB protein.
This one-to-one ratio makes apoB measurements incredibly useful. When you measure apoB levels in your blood, you're directly counting the number of potentially harmful cholesterol particles floating around in your bloodstream. This is different from measuring LDL cholesterol (often called "bad cholesterol"), which tells you the total amount of cholesterol in those particles but not how many particles there are (Sniderman et al., 2019).
Why does this distinction matter? Because cardiovascular risk relates more strongly to the number of cholesterol particles than to the amount of cholesterol they contain. Think of it this way: you're more likely to get hit crossing a highway if there are many cars, even if some of them are small, than if there are just a few large trucks. Similarly, having many cholesterol particles (high apoB) is more dangerous than having a smaller number of cholesterol-rich particles.
Variants in the APOB gene can cause your body to produce higher levels of apoB-containing particles, leading to elevated LDL cholesterol and increased atherosclerosis risk. The research shows that apoB levels predict cardiovascular events more accurately than traditional LDL cholesterol measurements, especially in people with diabetes, metabolic syndrome, or insulin resistance (Behbodikhah et al., 2021).
While both genes affect cardiovascular disease risk through cholesterol metabolism, they do so through different mechanisms:
Location of action: APOE primarily affects what happens after cholesterol particles are in circulation. Specifically, it influences how efficiently they're cleared from your blood and removed from tissues. APOB, on the other hand, determines how many atherogenic particles your body produces and releases into circulation in the first place.
Overlap with other conditions: APOE4 is unique in that it significantly increases risk for both heart disease and Alzheimer's disease, creating a link between cardiovascular and brain health that doesn't exist with APOB variants. APOB variants primarily affect cardiovascular risk without the same neurological implications.
Interaction with lifestyle factors: Research suggests that APOE4 carriers may be more sensitive to lifestyle and environmental factors than non-carriers. Studies have shown that physical inactivity, high saturated fat intake, smoking, and alcohol consumption increase dementia and cardiovascular disease risk more dramatically in APOE4 carriers than in non-carriers (Laitinen et al., 2006). This means that while healthy lifestyle choices benefit everyone, they may be especially powerful for people carrying the APOE4 variant.
Measurability: While you can get genetic testing to determine your APOE and APOB variants, you can also measure apoB protein levels directly through a blood test. Increasingly, cardiovascular specialists are recommending apoB measurement as a more accurate way to assess heart disease risk than traditional cholesterol panels alone.
Here's perhaps the most important message of this entire review: carrying higher-risk variants of APOE or APOB does not doom you to develop cardiovascular disease. These genetic variations increase your baseline risk, but lifestyle factors still play the dominant role in determining whether that risk becomes reality.
Population studies provide compelling evidence for this optimistic view. Research comparing people of West African ancestry living in Nigeria versus those living in the United States found that while APOE4 is common in both populations, the cardiovascular disease and Alzheimer's disease rates are dramatically higher in African Americans living in the United States (Zhao et al., as cited in Norwitz et al., 2021). Similarly, studies of Southern Italians show that those carrying APOE4 who live in Italy and follow a traditional Mediterranean lifestyle have normal longevity, while Italian Americans with the same genetic variant face significantly reduced lifespan.
What's different between these populations? Not their genes; those remain the same. What differs are their dietary patterns, physical activity levels, stress, social connections, and other lifestyle factors. This demonstrates that environment and behavior can either amplify or suppress genetic risk.
For both APOE and APOB variants, the scientific evidence points to the same conclusion: aggressive attention to modifiable risk factors can reduce your cardiovascular disease risk to levels comparable to people without these genetic variants. You may need to be more vigilant and more consistent with healthy habits than someone without these genetic risks, but you absolutely have the power to protect your heart.
Get the right testing done. During your next checkup, ask your doctor about apoB testing in addition to standard cholesterol panels, especially if you have a family history of early heart disease, diabetes, or metabolic syndrome. ApoB measurements provide more precise cardiovascular risk assessment than LDL cholesterol alone. If you have a strong family history of Alzheimer's disease or early cardiovascular disease, consider discussing APOE genetic testing with your healthcare provider to better understand your risk profile.
Prioritize a heart-healthy diet, especially if you're an APOE4 carrier. Research specifically examining APOE4 carriers suggests that dietary fat quality matters even more for this group. Focus on replacing saturated fats (found in red meat, butter, and full-fat dairy) with healthier fat sources like olive oil, avocados, nuts, and fatty fish. APOE4 carriers may benefit particularly from limiting saturated fat intake to less than 7% of total calories. Consider following a Mediterranean-style eating pattern, which has shown protective effects especially pronounced in APOE4 carriers (Laitinen et al., 2006).
Move your body regularly because it matters even more if you carry risk variants. Physical inactivity increases cardiovascular disease risk in everyone, but research shows this effect is amplified in APOE4 carriers. Aim for at least 150 minutes of moderate-intensity activity per week (like brisk walking) or 75 minutes of vigorous activity (like running or cycling). The good news is that studies show exercise benefits are just as powerful for APOE4 carriers as for non-carriers when people actually do the exercise. The key is consistency.
Manage your weight to optimize your cholesterol particle count. Excess body weight, particularly visceral fat around your midsection, increases the production of apoB-containing particles and worsens your overall cholesterol profile. Even modest weight loss of 6-12% of body weight has been shown to significantly reduce apoB levels and improve cardiovascular risk markers. For help understanding your current weight status and setting realistic goals, check out our BMR and TDEE calculator.
Don't smoke, and if you do, prioritize quitting. Smoking dramatically accelerates atherosclerosis and inflammation regardless of your genetic background, but research suggests the harmful effects may be particularly pronounced in APOE4 carriers. The encouraging news: cardiovascular risk begins declining within months of quitting and continues to improve for years afterward.
Have a focused conversation with your doctor. Come to your next appointment prepared with specific questions based on your genetic risk factors. Try asking: "Given that I carry [specific genetic variant], what should my target levels be for LDL cholesterol and apoB?" or "Are there specific lifestyle modifications that would be most beneficial given my genetic profile?" or "How often should I have my cardiovascular risk markers checked?" Your doctor can help you develop a personalized prevention plan that accounts for your unique genetic background alongside your other risk factors.
Knowing your genetic risk can be empowering, but information alone does not change outcomes. What matters most is building the daily habits that support cardiovascular health over time. If you want help turning concepts like nutrition, exercise, metabolic health, and prevention into something practical, explore our Complete Health & Wellness Education course. It was designed for beginners and gives you a structured, evidence-based path to building health habits that last.
Allele — Different versions of the same gene. For the APOE gene, the three main alleles are ε2, ε3, and ε4.
ApoB (apolipoprotein B) — A protein that sits on the surface of cholesterol-carrying particles. Every atherogenic particle has exactly one apoB molecule, making apoB levels a direct count of potentially harmful particles in your blood.
ApoE (apolipoprotein E) — A protein that helps transport cholesterol through your bloodstream and plays a role in clearing cholesterol from your blood and removing it from artery walls.
APOE — The gene that provides instructions for making apolipoprotein E protein. The gene comes in three main versions: ε2, ε3, and ε4.
APOE4 — A variant of the APOE gene associated with increased risk for both cardiovascular disease and Alzheimer's disease. You can carry zero, one, or two copies of this variant.
APOB — The gene that provides instructions for making apolipoprotein B protein. Variations in this gene can lead to higher production of atherogenic particles.
Atherosclerosis — The process where fatty deposits called plaques build up inside artery walls, narrowing the arteries and restricting blood flow. This can eventually lead to heart attacks and strokes.
Atherogenic particles — Cholesterol-carrying particles that can contribute to plaque buildup in artery walls. These include LDL particles, VLDL particles, and others.
Cardiovascular disease — A group of conditions affecting the heart and blood vessels, including coronary artery disease, heart attacks, strokes, and heart failure.
Endothelium — The thin layer of cells lining the inside of blood vessels. Damage to this lining is one of the first steps in developing atherosclerosis.
Foam cells — Immune cells that have consumed so much cholesterol that they become bloated and stuck in artery walls, contributing to plaque formation.
HDL cholesterol — High-density lipoprotein cholesterol, often called "good cholesterol." HDL particles remove excess cholesterol from tissues and transport it back to your liver for disposal.
Insulin resistance — A condition where your cells don't respond properly to insulin, requiring your body to produce more insulin to keep blood sugar levels normal. This often precedes type 2 diabetes and increases cardiovascular disease risk.
LDL cholesterol — Low-density lipoprotein cholesterol, often called "bad cholesterol." When LDL levels are too high, cholesterol can accumulate in artery walls.
Lipoproteins — Particles that transport cholesterol and other fats through your bloodstream. They consist of a core of fats surrounded by proteins.
Mediterranean diet — An eating pattern based on traditional foods from countries bordering the Mediterranean Sea, emphasizing vegetables, fruits, whole grains, beans, nuts, olive oil, and fish, with limited red meat and processed foods.
Metabolic syndrome — A cluster of conditions including high blood pressure, high blood sugar, excess abdominal fat, and abnormal cholesterol levels that together increase heart disease risk.
Modifiable risk factors — Risk factors you can change through lifestyle choices, such as diet, physical activity, smoking, and weight.
Non-modifiable risk factors — Risk factors you cannot change, such as age, biological sex, family history, and genetic variants.
Plaque — A buildup of cholesterol, immune cells, and other materials inside artery walls that narrows the artery and can rupture, causing blood clots.
Saturated fat — A type of fat found primarily in animal products (meat, butter, cheese) and some tropical oils that can raise LDL cholesterol levels when consumed in excess.
Triglycerides — Another type of blood fat. High triglyceride levels often occur alongside other metabolic problems and can contribute to cardiovascular disease risk.
Variant — A specific change in the DNA sequence of a gene that makes it different from the most common version. Variants can affect how well a protein functions.
VLDL — Very low-density lipoprotein, a type of cholesterol-carrying particle that transports triglycerides and can contribute to atherosclerosis.
Behbodikhah, J., Ahmed, S., Elyasi, A., Kasselman, L. J., De Leon, J., Glass, A. D., & Reiss, A. B. (2021). Apolipoprotein B and cardiovascular disease: Biomarker and potential therapeutic target. Metabolites, 11(10), 690. https://doi.org/10.3390/metabo11100690
Laitinen, M. H., Ngandu, T., Rovio, S., Helkala, E.-L., Uusitalo, U., Viitanen, M., Nissinen, A., Tuomilehto, J., Soininen, H., & Kivipelto, M. (2006). Fat intake at midlife and risk of dementia and Alzheimer's disease: A population-based study. Dementia and Geriatric Cognitive Disorders, 22(1), 99-107. https://doi.org/10.1159/000093478
Norwitz, N. G., Saif, N., Ariza, I. E., & Isaacson, R. S. (2021). Precision nutrition for Alzheimer's prevention in ApoE4 carriers. Nutrients, 13(4), 1362. https://doi.org/10.3390/nu13041362
Rovio, S., Kåreholt, I., Helkala, E.-L., Viitanen, M., Winblad, B., Tuomilehto, J., Soininen, H., Nissinen, A., & Kivipelto, M. (2005). Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. The Lancet Neurology, 4(11), 705-711. https://doi.org/10.1016/S1474-4422(05)70198-8
Safieh, M., Korczyn, A. D., & Michaelson, D. M. (2019). ApoE4: an intersection between cardiovascular disease and Alzheimer's disease. Frontiers in Neuroscience, 13, 116. https://doi.org/10.3389/fnins.2019.00116
Sniderman, A. D., Pencina, M., & Thanassoulis, G. (2019). ApoB: The power of physiology to transform the prevention of cardiovascular disease. Circulation Research, 124(10), 1425-1427. https://doi.org/10.1161/CIRCRESAHA.119.315019
Song, Y., Stampfer, M. J., & Liu, S. (2004). Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Annals of Internal Medicine, 141(2), 137-147. https://doi.org/10.7326/0003-4819-141-2-200407200-00013
Note: This review synthesizes information from multiple open-access scientific sources to provide accessible health education. It is not intended as medical advice. Always consult with your healthcare provider about your individual genetic risk factors and appropriate preventive strategies.
